Stem Cell Studies Prepare for Clinical Trials

Two federally funded studies are currently underway to find answers regarding timing and optimal dosage for stem cell therapy in newborns with cerebral palsy and adults who have had strokes.

According to Dr. Cesario V. Borlongan, a neuroscientist at the Medical College of Georgia, before clinical trials can begin, these answers are needed.

Researchers Plan to Begin Trials

Reports claim that if the laboratory studies replicate the results of the previous studies done, researchers hope they can begin the trials within two years.

Previous studies done on stem cell therapy revealed a 25 percent improvement in recovery for patients inflicted with certain disabilities.

“We are looking for different procedures that we can adopt from the laboratory for the clinic,” explains Dr. Bolongan. “We have at least 10 years of basic research that clearly shows that stem cells have the potential to be a new therapy.”

The Promise of Stem Cell Therapy

Dr. David Hess, chair of the MCG Department of Neurology, explains that through this research, they can find “a whole new way to target disease.”

After researchers found success in their model for adult stroke, they reportedly saw a potential for helping babies who have a loss of blood and oxygen during birth, which can cause cerebral palsy.

“Very young patients may be the biggest beneficiaries of cell therapy,” states Dr. James E. Carroll, chief of the MCG Section of Pediatric Neurology.

(Source: Science Daily)

Does your child have cerebral palsy? If so, please contact a cerebral palsy attorney who will ensure that you and your loved ones are receiving the legal help you deserve.